Status:
COMPLETED
Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension
Lead Sponsor:
Laboratoires Thea
Conditions:
Primary Open Angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the pharmacokinetics, efficacy and safety of T2345 versus an active comparator.
Eligibility Criteria
Inclusion
- Untreated bilateral newly diagnosed patients with primary open angle glaucoma
Exclusion
- Any ocular hypertension other than chronic open angle glaucoma
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01494753
Start Date
June 1 2008
End Date
December 1 2008
Last Update
February 7 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.